Aligning, Appraising, and Simplifying Scientific Data Strengthens Promotional Claims

June 20, 2024
Annalise Ludtke


The pharmaceutical industry faces the challenge of converting complex medical and scientific information into clear, effective promotional claims. This process is critical as it balances the need for accurate scientific communication with the requirement for impactful marketing. The stakes are high, as promotional materials must adhere to stringent regulatory standards while also appealing to healthcare professionals and patients. Missteps can lead to significant legal and financial repercussions, making it essential for pharmaceutical companies to get this process right.

How do teams navigate the complexities of transforming dense scientific data into clear, approvable promotional material without losing accuracy or impact?

On this episode of Amend & Progress, hosted by Annalise Ludtke, Joe DiCapite, Director of Strategy for the UK and Europe at Vodori, delves into the intricate process of converting medical and scientific information into claims. Together, they discuss the challenges, best practices, and the importance of inter-team collaboration in ensuring successful outcomes.

Key Discussion Points

  • Ensure appropriateness: Teams must first evaluate whether new scientific data aligns with their drug’s indication and regulatory constraints to determine its suitability for promotional claims.
  • Assess evidence quality: A thorough appraisal of the evidence’s quality, including study design and statistical significance, is crucial to ensure the claim’s credibility and withstand scrutiny from competitors and regulators.
  • Effective communication: Transforming complex scientific data into clear, impactful, and accurate claims requires simplifying jargon while maintaining precision, tailored to different audience needs, and considering the overall impression of the promotional material.

Joe DiCapite brings extensive experience in medical writing, medical affairs, and marketing. His background includes a strong foundation in the pharmaceutical industry, with a focus on critical appraisal and compliance processes. His expertise spans both the strategic and operational aspects of converting scientific data into promotional claims, making him a valuable voice in this field.

Recent Episodes

employee health
View episode

Employee health and well-being have become a critical focus for organizations in today’s rapidly evolving workplace. With the increasing prevalence of chronic stress and burnout, especially in healthcare, the stakes are higher than ever. Research shows that  80% of chronic diseases are preventable, emphasizing the need for effective workplace health strategies. How can leaders create…

MSK populations
View episode

Discover how a dynamic duo partnered with innovative, value-based strategies to revolutionize care for MSK populations. As musculoskeletal (MSK) conditions like osteoarthritis and back pain continue to rise, innovative partnerships are vital to delivering effective, value-based care. Recent studies show that MSK conditions are among the leading contributors to disability in the U.S., highlighting…

chief impact officer
View episode

As healthcare challenges become more complex, the role of a chief impact officer in healthcare systems is gaining unprecedented importance. Healthcare Rethink Host Brian Urban explores the growing significance of this role with Lorena Zimmer, the Chief Impact Officer at Denver Health. From her early days as a tobacco program specialist to her current…